ATS View
한국어

Genomictree KRX:228760KOSDAQ

지노믹트리 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h1
Articles, 7 days7
DART filings, 7 days1
Articles tracked14since Sep 11

In Q2 2026, Genomictree reported revenue of ₩842m, down 51.1% year on year, and an operating loss of ₩2.6bn. Genomictree (지노믹트리) appeared in 7 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Oct 28 with 4 articles. The most common catalyst was tech & capacity (3).

Filing signals 4 quarters of losses Screener

Genomictree quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩842m-51.1%−₩2.6bn−₩2.5bn
Q1 2026₩382m+20.6%−₩3.0bn−₩2.0bn
Q4 2025 derived₩826m+0.1%−₩2.6bn−₩2.0bn
Q3 2025₩897m+29.3%−₩3.4bn−₩2.8bn
Q2 2025₩1.7bn+207.5%−₩1.5bn
margin −87.5%		−₩1.5bn
Q1 2025₩316m+11.2%−₩3.7bn−₩3.0bn
Q4 2024 derived₩824m+24.6%−₩3.7bn−₩1.8bn
Q3 2024₩693m+30.3%−₩3.9bn−₩3.1bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Genomictree top stories 2 weeks, by number of outlets

  1. 1
    지노믹트리, 종양억제인자 2종 동시 전달 기술 국제학술지 게재 승인
    1 outlets · 2 articlesFirst report Oct 28 13:42 이데일리New technology
  2. 2
    지노믹트리, 방광암 재발 감시 임상 성과 국제학술지 게재
    1 outlets · 1 articlesFirst report Oct 26 10:19 메디파나뉴스New technology
  3. 3
    지노믹트리, 이중 mRNA 항암 전달기술 논문 게재 승인
    1 outlets · 1 articlesFirst report Oct 28 14:15 메디파나뉴스
  4. 4
    지노믹트리 대장암 진단키트 '얼리텍-C', 내년 1분기 보험등재 '윤곽'
    1 outlets · 1 articlesFirst report Oct 26 14:33 녹색경제신문
  5. 5
    지노믹트리, 방광암 진단 '얼리텍-B' 보험등재 추진…연 1193억 시장 겨냥
    1 outlets · 1 articlesFirst report Oct 30 13:23 리드경제
  6. 6
    지노믹트리 30일 온라인 기업설명회 개최
    1 outlets · 1 articlesFirst report Oct 28 23:12 비건뉴스

Latest Genomictree news Korean headlines